A deficiency of hepatic dihydropteridine reductase (DHPR) activity was found in a neurologically impaired infant with mild hyperphenylalaninemia and normal levels of hepatic phenylalanine hydroxylase. DHPR is required for the regeneration of tetrahydrobiopterin, an essential cofactor in aromatic amino acid hydroxylation, a necessary step in the biosynthesis of the neurotransmitters, dopamine and serotonin. Evidence for decreased synthesis of these transmitters in this patient was provided by the finding of reduced levels of homovanillic acid and 5-hydroxyindole acetic acid, metabolites of dopamine and serotonin, respectively, in the cerebrospinal fluid and urine. Treatment with dopamine and serotonin precursors, l-3,4 dihydroxyphenylalanine and 5-hydroxytryptophan, respectively, was associated with improvement in temperament and motor tone and less frequent seizures. However, there was no improvement in gross motor function or language development.
Skip Nav Destination
Article navigation
January 1979
Articles|
January 01 1979
Dihydropteridine Reductase Deficiency Associated With Severe Neurologic Disease and Mild Hyperphenylalaninemia
Thomas G. Brewster;
Thomas G. Brewster
Departments of Medicine and Neurology, Children's Hospital Medical Center; Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology; Section of Neurology, Department of Medicine, Peter Bent Brigham Hospital; Departments of Pediatrics and Neurology, Harvard Medical School, Boston, and the Laboratory of Neurochemistry, National Institutes of Mental Health, Bethesda, Maryland
Search for other works by this author on:
Michael A. Moskowitz;
Michael A. Moskowitz
Departments of Medicine and Neurology, Children's Hospital Medical Center; Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology; Section of Neurology, Department of Medicine, Peter Bent Brigham Hospital; Departments of Pediatrics and Neurology, Harvard Medical School, Boston, and the Laboratory of Neurochemistry, National Institutes of Mental Health, Bethesda, Maryland
Search for other works by this author on:
Seymour Kaufman;
Seymour Kaufman
Departments of Medicine and Neurology, Children's Hospital Medical Center; Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology; Section of Neurology, Department of Medicine, Peter Bent Brigham Hospital; Departments of Pediatrics and Neurology, Harvard Medical School, Boston, and the Laboratory of Neurochemistry, National Institutes of Mental Health, Bethesda, Maryland
Search for other works by this author on:
Jan L. Breslow;
Jan L. Breslow
Departments of Medicine and Neurology, Children's Hospital Medical Center; Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology; Section of Neurology, Department of Medicine, Peter Bent Brigham Hospital; Departments of Pediatrics and Neurology, Harvard Medical School, Boston, and the Laboratory of Neurochemistry, National Institutes of Mental Health, Bethesda, Maryland
Search for other works by this author on:
Sheldon Milstien;
Sheldon Milstien
Departments of Medicine and Neurology, Children's Hospital Medical Center; Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology; Section of Neurology, Department of Medicine, Peter Bent Brigham Hospital; Departments of Pediatrics and Neurology, Harvard Medical School, Boston, and the Laboratory of Neurochemistry, National Institutes of Mental Health, Bethesda, Maryland
Search for other works by this author on:
Israel F. Abroms
Israel F. Abroms
Departments of Medicine and Neurology, Children's Hospital Medical Center; Laboratory of Neuroendocrine Regulation, Department of Nutrition and Food Science, Massachusetts Institute of Technology; Section of Neurology, Department of Medicine, Peter Bent Brigham Hospital; Departments of Pediatrics and Neurology, Harvard Medical School, Boston, and the Laboratory of Neurochemistry, National Institutes of Mental Health, Bethesda, Maryland
Search for other works by this author on:
Pediatrics (1979) 63 (1): 94–99.
Article history
Received:
March 31 1978
Accepted:
May 24 1978
Citation
Thomas G. Brewster, Michael A. Moskowitz, Seymour Kaufman, Jan L. Breslow, Sheldon Milstien, Israel F. Abroms; Dihydropteridine Reductase Deficiency Associated With Severe Neurologic Disease and Mild Hyperphenylalaninemia. Pediatrics January 1979; 63 (1): 94–99. 10.1542/peds.63.1.94
Download citation file:
0 Comments
Comments Icon
Comments (0)
Sign in
Don't already have an account? Register
Pay-Per-View Access
$25.00
0
Views
0
Citations